PDS Biotechnology Corporation (PDSB) Stock Price

2.83 ▲ +0.07 (+2.54%)
Open: 2.76 Vol: 189.4K Day's range: 2.69 - 2.85 Jan 22, 16:00 EST
IEX Real-Time Price
Free Stock Screener
Loading chart ...
PDSB Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.81▲ 2.80▲ 2.80▲ 2.75▲ 2.46▲
MA10 2.80▲ 2.81▲ 2.81▲ 2.65▲ 2.33▲
MA20 2.84▲ 2.80▲ 2.78▲ 2.48▲ 2.31▲
MA50 2.76▲ 2.71▲ 2.66▲ 2.27▲ 1.92▲
MA100 2.66▲ 2.57▲ 2.48▲ 2.28▲ N/A    
MA200 2.50▲ 2.38▲ 2.35▲ 2.11▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.004▼ -0.005▼ -0.007▼ 0.037▲ N/A    
RSI 57.406▲ 58.387▲ 59.809▲ 64.597▲ N/A    
STOCH 56.923     36.908     42.845     75.757     53.906    
WILL %R -17.241▲ -29.412     -29.412     -12.500▲ -9.434▲
CCI 86.873     46.523     66.148     91.347     200.328▲
Latest Filters Detected On PDSB
CDL $PDSB Doji Candlestick Pattern Detected Set Alert
▲ GAP $PDSB Open Gap Up %2 Set Alert
▼ MACD $PDSB MACD(12,26,9) Crossed Below Zero Set Alert
RSI $PDSB RSI(14) Crossed Below 50 Set Alert
PDS Biotechnology Corporation News
Ellis Investment Partners LLC Acquires 15,600 Shares of PDS Biotechnology Co. (NASDAQ:PDSB)
Saturday, January 23, 2021 02:31 AM
Ellis Investment Partners LLC boosted its holdings in PDS Biotechnology Co. (NASDAQ:PDSB) by 693.3% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange ...
PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in ...
Friday, January 15, 2021 12:57 AM
(GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s ...
PDS Biotech Releases White Paper Detailing the Potential of the Versamune Platform in Overcoming a Major Limitation of Immuno-Oncology
Thursday, January 14, 2021 06:30 AM
FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...
PDSB historical stock data
date open high low close volume
22/01/21 2.76 2.85 2.69 2.83 189,400
21/01/21 2.84 2.867 2.76 2.76 140,900
20/01/21 2.73 2.93 2.725 2.82 695,900
19/01/21 2.70 2.74 2.63 2.70 318,600
15/01/21 2.77 2.85 2.62 2.63 335,600
14/01/21 2.63 2.85 2.626 2.76 565,600
13/01/21 2.49 2.60 2.44 2.60 264,300
12/01/21 2.49 2.55 2.45 2.50 266,800
11/01/21 2.39 2.50 2.35 2.49 245,350
08/01/21 2.53 2.62 2.35 2.39 358,800
Quote Details
52wk Low:0.62
52wk High:4.98
Vol:189.4K
Avg Vol(3m):9.5M
1Y Chng:+39.41%
1M Chng:+32.24%
Add to Watch List
More Information
Index NASDAQ Composite
Market Cap. 63.00M